Verve Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Aug '25 Aug 4, 2025	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Market Capitalization	204	85	102	116	147
Market Cap Growth	-	-17.27%	-11.37%	-21.42%	-
Enterprise Value	-	85	102	115	-
Last Close Price	83.49	35.64	40.21	38.90	43.51
PE Ratio	-	-	-	3.28	85.31
PS Ratio	9.61	3.99	5.51	7.09	58.28
PB Ratio	1.26	0.52	0.60	0.61	0.84
P/OCF Ratio	30.25	12.56	6.53	8.60	-
EV/Sales Ratio	-	3.99	5.50	7.08	-
EV/EBIT Ratio	-	5.31	6.22	8.06	-
Asset Turnover	0.13	0.13	0.10	0.09	-
Quick Ratio	35.74	35.74	0.46	0.27	0.14
Current Ratio	35.75	35.75	0.46	0.27	84.56
Return on Equity (ROE)	-1.15%	-1.15%	-2.40%	19.24%	-
Return on Assets (ROA)	5.98%	5.98%	5.69%	4.88%	-
Return on Capital (ROIC)	5.98%	5.98%	5.69%	4.89%	-
Earnings Yield	-0.93%	-2.25%	-4.25%	30.51%	1.17%
Payout Ratio	-	-	-	38.20%	18.80%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.